Artemis Therapeutics Inc.
ATMS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $66,188 | $25 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $66,188 | $25 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 82.6% | – | – | – |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | -431.8% | – | – | – |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -434.4% | – | – | – |
| EPS Diluted | -0.01 | -0.007 | -0.024 | -0.024 |
| % Growth | -44.9% | 70.6% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |